MedTrace Logo

Clinical Evaluation of a Myopia Control Lens in Slowing Myopia Progression

NCT05331378 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2025-08-07

No results posted yet for this study

Summary

This is a monocenter, randomized, controlled, parallel-group, double-masked clinical trial to evaluate the effectiveness of test lens in slowing myopia progression with respect to axial length elongation at baseline compared to a single vision spectacle lens (control). A total of 80 children will be recruited where 40 subjects will be allocated either to wear test lenses (group 1) or control lenses (group 2) for 1 year through randomization.

Conditions

  • Myopia, Progressive
  • Myopia

Interventions

DEVICE

Test myopia control lenses

A myopia control spectacle lenses (test lenses) will be given to 1 arm to wear for 12 months.

DEVICE

Single vision lenses

A single vision spectacle lenses (control lenses) will be given to 1 arm to wear for 12 months.

Sponsors & Collaborators

  • Essilor International

    lead INDUSTRY

Principal Investigators

  • Andrew Tan · Essilor R&D Centre Singapore

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
8 Years
Max Age
13 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-04-25
Primary Completion
2024-10-29
Completion
2025-10-31

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05331378 on ClinicalTrials.gov